(HealthDay)—Routine urine samples can be used to test for medication adherence in patients with type 2 diabetes, according to a study published in the June issue of Diabetes Care.
May 23, 2019
0
2
(HealthDay)—In patients with type 1 diabetes, treatment with dapagliflozin for 24 weeks improves time in range, mean glucose, and glycemic variability, according to a study published online April 9 in Diabetes Care.
Apr 26, 2019
0
2
(HealthDay)—Testosterone therapy (TTh) can prevent progression to type 2 diabetes (T2D) in men with prediabetes and hypogonadism, according to a study published online March 12 in Diabetes Care.
Mar 15, 2019
0
1
(HealthDay)—There is seasonal variation in achievement of the guideline targets for hemoglobin A1c (HbA1c), blood pressure (BP), and low-density lipoprotein (LDL) cholesterol among persons with type 2 diabetes mellitus ...
Feb 27, 2019
0
0
(HealthDay)—Rates of diabetes screening are high, with hemoglobin A1c (HbA1c) used less but more likely to result in clinical diagnosis, according to a study published online Feb. 6 in Diabetes Care.
Feb 11, 2019
0
0
In the United States, the drug price for insulin has skyrocketed over the last two decades. While the price has increased for all forms of insulin, newer, "analogue" insulin medications such as glargine and lispro have become ...
Jan 29, 2019
0
9
(HealthDay)—Ensuring a short duration between dinner and bedtime has no effect on hemoglobin A1c (HbA1c) levels in middle-aged and older Japanese adults, according to a study published online Jan. 22 in BMJ Nutrition, Prevention ...
Jan 24, 2019
0
3
(HealthDay)—Many primary care patients are not given tests recommended for monitoring diabetes, according to a study published in the December issue of Family Medicine and Community Health.
Jan 11, 2019
0
8
(HealthDay)—Long work hours (≥60 hours/week) are associated with poor glycemic control in young Japanese men with type 2 diabetes, according to a study published in the January issue of the Journal of Diabetes Investigation.
Jan 9, 2019
0
0
In a first-in-human clinical trial reported today in Blood, the investigational drug sutimlimab appeared to be effective in treating cold agglutinin disease, a rare chronic blood disorder for which there are currently no ...
Dec 17, 2018
0
0
